SCHEMBL20128629

SCHEMBL20128629

CCCCCCCCC(CCCCCCC)OC(=O)OC

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ZDHHC7 Q9NXF8 1/20 0.53
GPR84 Q9NQS5 5/20 0.45
FFAR1 O14842 1/20 0.45
ABCB1 P08183 1/20 0.45
FAAH O00519 4/20 0.45
CNR1 P21554 1/20 0.45
CNR2 P34972 1/20 0.45
MAPT P10636 2/20 0.44
MAPK1 P28482 1/20 0.44
LMNA P02545 2/20 0.44
USP2 O75604 1/20 0.44
EPHX1 P07099 1/20 0.44
LCK P06239 1/20 0.44
PPARD Q03181 1/20 0.44
ZDHHC20 Q5W0Z9 1/20 0.44
ZDHHC2 Q9UIJ5 1/20 0.44
PLA2G2A P14555 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3781465 1.00 ZDHHC7 (0.53) ZDHHC7GPR84FFAR1ABCB1FAAH
SCHEMBL27686924 1.00 ZDHHC7 (0.53) ZDHHC7GPR84FFAR1ABCB1FAAH
SCHEMBL29175475 0.91 GPR84 (0.48) ZDHHC7GPR84FFAR1FAAHMAPT
SCHEMBL7649131 0.91 GPR84 (0.48) ZDHHC7GPR84FFAR1FAAHMAPT
SCHEMBL29065655 0.91 GPR84 (0.48) ZDHHC7GPR84FFAR1FAAHMAPT
SCHEMBL7645699 0.91 GPR84 (0.48) ZDHHC7GPR84FFAR1FAAHMAPT
SCHEMBL7644829 0.91 GPR84 (0.48) ZDHHC7GPR84FFAR1FAAHMAPT
SCHEMBL8518835 0.91 GPR84 (0.48) ZDHHC7GPR84FFAR1FAAHMAPT
SCHEMBL7645314 0.91 GPR84 (0.48) ZDHHC7GPR84FFAR1FAAHMAPT
SCHEMBL7940292 0.91 GPR84 (0.48) ZDHHC7GPR84FFAR1FAAHMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180127343-A1 NOVEL COMPOUNDS FOR TREATING DIABETES THE CHINESE UNIVERSITY OF HONG KONG (CN) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127343-A1 NOVEL COMPOUNDS FOR TREATING DIABETES GPR119, SLC5A2, DPP4 ZDHHC7 239/4885GPR84 987/4885FFAR1 857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.